BML Investment Partners, L.P. 13D and 13G filings for Terns Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-08 5:24 pm Unchanged | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | 0 (Unchanged) | Filing |
| 2023-02-08 5:23 pm Sale | 2023-02-08 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 0 0.000% | -1,764,274 (Position Closed) | Filing |
| 2022-06-07 4:41 pm Purchase | 2022-06-01 | 13G | TERNS PHARMACEUTICALS INC TERN | BML Investment Partners, L.P. | 1,764,274 7.000% | 1,764,274 (New Position) | Filing |